Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.49 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTPRB | P23467 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13601337 | 0.88 | LOXL2 (0.59) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL13601226 | 0.81 | SLC7A5 (0.42) | CYP4F2CYP4A11SLC7A5ALDH1A1 | |
| SCHEMBL4682498 | 0.79 | LOXL2 (0.67) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL6820222 | 0.79 | MAOB (0.45) | NR1H4 | |
| SCHEMBL6820227 | 0.79 | MAOB (0.45) | NR1H4 | |
| SCHEMBL30010757 | 0.77 | P4HB (0.60) | RAB9AALDH1A1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL2136421 | 0.77 | P4HB (0.60) | RAB9AALDH1A1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL2136416 | 0.77 | P4HB (0.60) | RAB9AALDH1A1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL697890 | 0.77 | LOXL2 (0.68) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL558157 | 0.77 | TSHR (0.53) | LOXL2CYP4F2CYP4A11SLC7A5RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | F12, ANXA1, F11 | LOXL2 477/4885CYP4F2 821/4885CYP4A11 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.